Why Particle Size Matters in Inhalable Drugs
For Dry Powder Inhalers (DPIs), API particles must typically be in the 1–5 µm range to ensure optimal lung penetration and therapeutic efficacy.
Jetpharma’s Inhalation Micronization Expertise
We offer:
- Jet milling for DPI formulations
- Tight control over D10/D50/D90 specs
- Laser diffraction particle analysis
- Batch traceability and repeatability
All processes follow GMP guidelines for respiratory drug development.
Optimized for Stability and Formulation Performance
We tailor micronization to match flowability, blending performance, and carrier compatibility (e.g., lactose-based blends).
Improve your inhalation product performance with Jetpharma’s DPI-grade micronization.